Since angiotensin-II receptor 1 (AT1R) antagonism reduces aneurysm formation and aortic events in MFS patients (27, 28, 29) and mice (30), a beneficial effect of C1-INH Cetor® could be expected for just this reason. This evidence concerns the gene SERPING1 and aneurysm.